[Severe hypercalcemia after substitution of prolonged deficiency of vitamin D in a patient with primary hyperparathyroidism]

Presse Med. 2014 Dec;43(12 Pt 1):1391-4. doi: 10.1016/j.lpm.2014.04.025. Epub 2014 Oct 24.

[Article in French]

Authors

Marc Duquenne¹, Carole Duquenne², Jean-Claude Souberbielle³, Antoine Hamy⁴, Vincent Rohmer⁵

Affiliations

¹ Centre hospitalier du Mans, service de diabétologie, endocrinologie, 72037 Le Mans cedex 9, France. Electronic address: mark.duquenne@free.fr.
² Centre hospitalier universitaire de Brest, service de rhumatologie, 29609 Brest cedex, France.
³ Hôpital Necker-enfants malades, service d'explorations fonctionnelles, 75015 Paris, France.
⁴ Centre hospitalier universitaire d'Angers, service de chirurgie viscérale, 49033 Angers cedex, France.
⁵ Centre hospitalier universitaire d'Angers, service endocrinologie, diabétologie, nutrition, 49033 Angers cedex, France.

PMID: 25443637
DOI: 10.1016/j.lpm.2014.04.025

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Absorptiometry, Photon
Adenoma / blood
Adenoma / diagnosis
Adenoma / surgery
Aged
Bone Density / drug effects
Calcifediol / adverse effects*
Calcifediol / therapeutic use*
Calcium / blood
Female
Follow-Up Studies
Humans
Hypercalcemia / blood
Hypercalcemia / chemically induced*
Hypercalcemia / diagnosis
Hyperparathyroidism, Primary / blood
Hyperparathyroidism, Primary / complications*
Hyperparathyroidism, Primary / surgery
Parathyroid Hormone / blood
Parathyroid Neoplasms / blood
Parathyroid Neoplasms / diagnosis
Parathyroid Neoplasms / surgery
Parathyroidectomy
Vitamin D / analogs & derivatives
Vitamin D / blood
Vitamin D Deficiency / blood
Vitamin D Deficiency / drug therapy*

Substances

Parathyroid Hormone
Vitamin D
25-hydroxyvitamin D
Calcifediol
Calcium